chrisvoncsefalvay/vaers-outcomes huggingface dataset:
no adverse event; patient inadvertently received HAVRIX, MMR II and VARIVAX on 11/4/2022. The same vaccines- HAVRIX, MMR Iand VARIVAX had been administered on 6/30/2022; This spontaneous report was received from a nurse and refers to a 16-month-old patient of an unspecified gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided.  On 30-JUN-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, recombinant Human albumin (rHa), dose 0.5 ml, lot #T029550, expiration date: 01-SEP-2022, administered subcutaneously (anatomical location was not provided), varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, dose 0.5 ml, lot #U002397, expiration date: 22-JAN-2023, administered subcutaneously for prophylaxis (anatomical location was not provided) and hepatitis a vaccine inactivated (HAVRIX), administered for prophylaxis (dose, route of administration, lot #, expiry date, and anatomical location were not provided). On 04-NOV-2022, the patient inadvertently received (product administration error) measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, recombinant Human albumin (rHa), dose 0.5 ml, lot #U029619, expiration date: 22-SEP-2023, administered subcutaneously (anatomical location was not provided), varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, dose 0.5 ml, lot #U008182, expiration date: 04-NOV-2023, administered subcutaneously for prophylaxis (anatomical location was not provided) and hepatitis a vaccine inactivated (HAVRIX), administered for prophylaxis (dose, route of administration, lot #, expiry date, and anatomical location were not provided). No additional adverse events reported.
Received annual flu shot as usual, but injection given superior to deltoid muscle into the left shoulder capsule.  Pain & weakness have been present 8 weeks, typically only last 1 - 2 days.
Pt developed edema and erythema L thigh where vaccine was administered the day before. Rx: Beadryl, continueation of prelone syrup as previously prescribed, Keflex x 10 days.
I am experiencing brain-fog like symptoms. My sensations are dulled, I cannot process what's going around me the way I used to be able to. For example, I am having trouble holding conversations that require a lot of thinking. I am quick to lose focus, and it is difficult to engage in cognitive activities because of it. It feels like I am "up in the clouds" as if I am experiencing a drunk-like feeling or marijuana high. It is as if I am able to feel all the sensations, but somewhere in the brain, there is a disconnect happening that I am not able to be as sensitive as I used to be. I am dull to the usual pain sensations I would normally feel (e.g. when I scratch a part of my body, or when I am in an uncomfortable position for a longer time). Just overall, my sensations are not as sensitive so everything seems duller. I do not feel like I'm 100% there in my body.  I have not had any adverse side effects to other vaccines I have received in the past. I may have gotten the usual flu-like symptoms but nothing as bizarre as the symptoms I am experiencing currently.
No adverse event.  HEP A #1 given at 2 months of age.
This non-serious spontaneous case, initial and follow up version are being processed together on 02-Nov-2018 received from other health professional, concerns a 61-year-old, adult female patient. On 28-Sep-2018, FLUCELVAX QIVc was exposed to 9.5 degree Celsius for 2 hours and 43 minutes which was a first-time excursion of the product. The maximum temperature (Tmax) was 9.5 Celsius for 2 hours and 48 minutes. On the same day, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252235, expiry date: 30-Jun-2019] that underwent temperature excursion. No adverse events were reported after the vaccination. Follow-up received from other health professional on 19-Nov-2018: The dose (0.5 ml), route of administration (intramuscular), anatomical location (deltoid) were added in the product tab. The date of vaccination and temperature excursion date (29-Sep-2018) were added in the event tab. The narrative was amended accordingly.
Hive like bumps on face (mainly around the forehead and cheeks), on chest,; and a little bit around the site of the shot; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 18Mar2021 at 14:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medication within two weeks of vaccination. On 19Mar2021 at 07:00, the patient experienced hive like bumps on face (mainly around the forehead and cheeks), on chest, and a little bit around the site of the shot. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had been tested for COVID-19. On 08Apr2021, the patient gave nasal swab for SARS-CoV-2 PCR test and the result was negative. The clinical outcome of the event hive like bumps on face (mainly around the forehead and cheeks), on chest, and a little bit around the site of the shot was recovered on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
"led vein" was stuck up on 2 stents; First dose of the Pfizer BioNtech Covid-19 Vaccine on 27Feb2021/ second dose of the vaccine on Aug2021; chest pain; arm pains /left shoulder; Increased need to get up and go to bathroom during night; This is a spontaneous report from a contactable consumer (patient). This consumer reported events after two doses of the vaccine. This is the second of two reports. This report is for the second dose. This 66-year-old male patient received first dose of BNT162B2 (COMIRNATY, lot number EW0167), via unspecified route of administration in left shoulder (arm) on 02Aug2021 at patient age of 66-year-old as single dose for COVID-19 immunisation. Medical history included blood pressure, diabetes diagnosed 12 years ago and apnea on Cpap breathing machine for 7-8 years. Family history included father died of diabetes 20 years ago. Concomitant medications included blood pressure and diabetes medication, prostate medication. None prior vaccinations within 4 weeks. The patient previously received first dose of BNT162B2 (COMIRNATY, Batch/lot number: EN6198), on 27Feb2021 14:00-15:00 at patient age of 65-year-old as single dose for COVID-19 immunisation and experienced chest pain, arm pain, heart attack and 4 heart blockages. 3-4 days after he took the second vaccine (Aug2021), he started having these chest and arm pains again and it was getting worse. The patient had a PET CT scan and selective coronary arteriogram. The patient stated "led vein" was stuck up on 2 stents (2 more blockages to put a stent in). The patient had 2 stents placed in the LAD on 30Sep2021. The patient was hospitalized from 03Sep2021 to 01Oct2021. The patient stated that prior to getting the vaccine, he had no chest pain or any heart issues. The patient stated that the vaccine might be triggering heart attack or blockages. The patient stated he was hurting. His chest felt like he had been stung by bees. It was a lot of pressure like an elephant had him pinned to ground when he had his heart attack. Now, it feels like bees and sensation goes across chest. His left shoulder was killing him. He does not know if this is because of when they put stents in they went in through left arm and right groin. He was worse now than before he had the 4 bypasses as far as feeling bad. He was almost to the suicidal point, later stated he was not suicidal and would not kill himself, it was just that the pain was bad. The patient had Increased need to get up and go to bathroom 4-5 times a night in either Aug2021 or Sep2021. He at first said it was not relevant and then said he never thought about it. He was already having problems with getting up 1-2 times a night and now it is 4-5 times a night. The outcome of the event chest pain and increased need to get up and go to bathroom was not resolved. The outcome of the event heart blockages was recovered/resolved with sequel. The outcome of the other event was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101317519 same patient, same drug (different dose), different event
I have developed Shingles after a week of my 2nd dose Pfyzer\BioNTec.   I have seen others patients reported same  after BioNTec, but health officials debunked the theory.  In my view its worth to observe Shingles cases linked to BioNT
Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concomitant products included LORAZEPAM and COLECALCIFEROL (VIT D3) for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 17-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.            Blood pressure medications have been used by patient. No Treatment medications are provided.   This case was linked to MOD-2021-361515 (Patient Link).
Felt warmth flowing down arm right after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Felt warmth flowing down arm right after vaccination) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A1A and 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Latex allergy.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Felt warmth flowing down arm right after vaccination). At the time of the report, VACCINATION SITE WARMTH (Felt warmth flowing down arm right after vaccination) outcome was unknown. Not Provided          Concomitant medications included Pain medications. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.
Swollen "bump" on left wrist (same arm as vaccine given) larger than a grape and achey
Muscle spasms; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle spasms) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced MUSCLE SPASMS (Muscle spasms). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Muscle spasms) outcome was unknown. Not Provided          40 minutes after receiving the vaccine, patient had muscles spasms.  Concomitant medications were not reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-080360 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up received and does not contain any significant information: Mailing Address updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080360:1st dose event
Entire face started tingling about 5 hrs after injection. Cntinued for 3 days of tingling for 1-3 hours then would go away for about 2 hours before coming back. After the 3rd day, left side of face is numb, no longer tingling. The numbness is constant and has not got any better over the past 20 hours.
Information has been received from a registered nurse concerning an adolescent female patient who was vaccinated with a dose of varicella virus vaccine live. Several years later, the patient presented to the medical office with a mild case of chicken pox. No other symptoms were reported. prescription drug therapy was not required. The reporter mentioned that the patient's sibling and about a dozen other patients also developed a mild case of chicken pox post vaccination with varicella virus vaccine live. Additional information is not expected.
Developed itching on day of 2nd shot. Then developed rash on chest, back, neck, shoulders, arms. He was treated at Clinic with Keflex and prednisone for Folliculitis & then by his PCP with Doxycycline for bacterial or Pityriasis rosea. Rash & itching continued & he was seen on 5/13/21 & treated with Tetracycline cream & Allegra. Biopsy consistent with Hypersensitivity Reaction. Rash is improving.
Rash on leg; Fever; This is a spontaneous report from a contactable consumer. This consumer reported for a 17-year-old female patient (sister).  A 17-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: ER8736, Expiry date: unknown) via an unspecified route of administration, administered in left arm on 17May2021 as dose 2, single for COVID-19 immunization. Medical history was reported as none. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2(PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: EW0170, Expiry date: reporter stated, "I have a date it's 26Apr2021 for the first one. No there is no expiration date) via an unspecified route of administration, on 26Apr2021 as dose 1, single for COVID-19 immunization. On 18May2021, the patient experienced fever. On 19May2021, patient experienced rash on leg. Reporter reported that we got the vaccine two days ago and my sister had a fever yesterday and today she woke up with a rash on her legs. We just want to know if we should be concerned or not or if it is actually something normal, we were just wondering about it. Reporter stated, she started experiencing the rash today, yesterday she had a fever. Treatment for Adverse event: Reporter stated, she said that she took some medicine for fever. We think it is because of that we just want to make sure that it wasn't something more serious. Reporter stated, she said she took Tylenol and Advil for the treatment of the event fever 2 times yesterday, 500 mg each for Tylenol, Advil 200 mg. The outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Information has been received from a consumer concerning her 23 month old niece who a few years ago was vaccinated with a 0.5 ml dose of VARIVAX (Merck). The consumer reported that her niece was diagnosed with shingles lesion on forehead on 26-JUL-2010. At the time of the report the patient was recovering. The patient sought unspecified medical attention. Additional information has been requested.
Day of vax dev 101 F over 1st 24 hrs,controlled /w APAP & resolved /p 1 day, well until 21Nov90 dev T 103.5 lasted through nite,Called MD 22Nov90 said"prob from MMR"@ 10 am eyes rolled back &had sz,to ER & dx Lt OM.  Had T since w/o sz.
One week after receiving vaccination patient woke up with swollen red eyes/puffy. No pain or itching. No other subsequent swelling at time of assessment over the phone. No other explanation to symptoms besides vaccine per patient. Patient referred to doctor for follow up and instructed to call 911 if a medical emergency.
NASAL CONGESTION, RUNNY NOSE, SORE THROAT, DRY COUGH, GENERAL MALAISE
I am a 43 YO female with no history of low iron. I donate blood every 3 months, and I get a physical with bloodwork done every year and my iron has always been on the high end (HGB ~14-15). I went to donate blood and was rejected. My HGB was 11. Went for blood workup, saw a hematologist, my ferratin was 2 and HGB dropped to 9. I even have iron induced PICA. Went for endoscopy/colonoscopy, totally normal. Tested for celiac, nope. I am starting 5 weeks of iron infusions on Monday.  I had my 2 Covid Pfizer vaccines in 2020 and early 2021. First Moderna booster in 11/2021. I had no issues with anemia. I had my second Moderna booster on 5/23/22 and was rejected for donating blood the first week of July.
Headache, Myalgia, Fatigue, shortness of breath, chills Narrative:
Patient expired the same day as receiving the vaccine. Nursing home reports no change in condition, respiratory condition, or temperature prior to finding him deceased.
I was vaccinated on 10 of August and I continue to get sicker every day . I have a phone appointment with my doctor tomorrow.
This spontaneous report as received from a Medical assistant refers to an unknown number of patients of unknown age and gender. The reporter mentioned that an unknown number of patients have received VARIVAX (Merck) (lot number and expiry date not reported) (dosing regimen and frequency unknown) from January 2013 to 16-DEC-2013 that may had an unknown number of excursions with temperatures from 3 degrees C to 7 degrees C and each excursion being 64 hours. No adverse effects reported. No product quality issue was reported. Follow-up information has been received from a medical assistant (who called to report specific administration dates), concerning a patient of unknown age and gender. On 05-SEP-2013 the patient had received a dose of VARIVAX (Merck) (lot number # H018979, exp. date: 24-OCT-2014) (dosing regimen and frequency were not provided). This dose of VARIVAX (Merck) had an unknown number of excursions with temperatures from minus 3 Celsius degree to minus 7 Celsius degree and each excursions being 64 hours. No adverse experiences were reported. This is one of 9 reports from the same source (# 1312USA011519; #1312USA011525; #1312USA011520; #1312USA011521; #1312USA011522; #1312USA008561; #1312USA011524; #1312USA011526). Additional information has been requested.
I had the first dose of the vaccine on December 28, 2020. There was no reaction at all. The second dose I took on January 25th at 10:45 AM. There was no immediate reaction. Six hours later I began to be fatigued. No appetite, moderate nausea and continued fatigue. (Not achy, no fever or chills). The next day was pretty much the same, no appetite, moderate nausea, continued fatigue.   This symptoms continued until 9PM and like a light switch, I felt much better.  At the injection site there was a hard knot (making my arm look like I had very nice biceps!), sore only when pressure was applied. This area stayed hard and larger than normal for about 6 days.
malaise; fever; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (malaise) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In October 2023, the patient experienced MALAISE (malaise) and PYREXIA (fever). At the time of the report, MALAISE (malaise) and PYREXIA (fever) had not resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.       No concomitant medication was reported.  Patient had reasonable exposure to individuals who seemed sick. She took a card test regularly to determine if she has covid. The card test she took today was positive. The test she took expired in July. She was unsure if the card test is for antibodies or some other indicator.  Dosage text was reported as unknown. No treatment information was reported.
Right arm and left arm tingles and falls asleep. Toes on both feet tingle. Tingling sensations on tips of fingers on both hands
Fever on second night, with chills and sweats. Itching at vaccine site from day 3 to 5, with sensation as if needle was still present.  "Stain" like reddish discoloration around the area of the injection site around 3 1/2" wide and 2" high appeared and remains present.  .
Severe chills and muscle ache starting approximately 9 hours after receiving the .25mg Moderna Covid-19 booster shot.  Medicated with Tylenol 1000mg  Symptoms lasting more that 12 hours
Case number PHEH2014US020680, is an initial spontaneous report from a nurse received on 13 Oct 2014. This report refers to a 60-year-old female patient. Concurrent conditions included diabetes. No concomitant medication was reported. The nurse does not have the vaccination history of the patient and was not sure if the patient had FLUVIRIN or another flu vaccine last year. She was vaccinated with FLUVIRIN (batch number: not reported) intramuscularly on 01 Oct 2014. Approximately two weeks after the vaccination, she experienced cold, neuropathy, cramping in the legs, pain in neck and arms and bilateral pain in her rotator cuff. The nurse expressed concern that are the symptoms related to the flu vaccine or the patient diabetes. The outcome of the events was unknown. Seriousness and causality was not reported. Seriousness assessment of the event neuropathy was upgraded based on the list.
Migraines are worse.  Have to seek bedrest.  Becomes very I?ll. Onset nausea and headaches. I had migraines previously but these are more severe . I have not seek treatment yet. Taking Motrin.
She also had no appetite; didn't feel really good; diarrhea; dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (She also had no appetite), MALAISE (didn't feel really good), DIARRHOEA (diarrhea) and DIZZINESS (dizzy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disorder (She had heart problems for several years.). Concomitant products included PROPAFENONE, AMLODIPINE and ESTRADIOL (ESTROGEN) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced DECREASED APPETITE (She also had no appetite), MALAISE (didn't feel really good), DIARRHOEA (diarrhea) and DIZZINESS (dizzy). In February 2021, MALAISE (didn't feel really good), DIARRHOEA (diarrhea) and DIZZINESS (dizzy) had resolved. At the time of the report, DECREASED APPETITE (She also had no appetite) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient mentioned that she doesn't have her female parts which have been going on for several years. Concomitant medications include anti-depressant medications. For dizziness she just laid down. No treatment medications were provided by the reporter.   This case was linked to MOD-2022-448789 (Patient Link).
Started as a pinprick rash a few hours after injection and to a full blown hives rash on left armpit. Continued to get more inflamed and I went to the ER. They gave me IV steroids and Benadryl. Helped but I still have the rash.